Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 2013-11-25 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 2024-10-12 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 2013-11-25 |
Catherine Boule
BRD | Director/Board Member | - | - |
Alain Parthoens
BRD | Director/Board Member | 66 | 2018-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12.69M | ||
| +2.87% | +4.57% | +68.97% | +119.22% | 55.19B | ||
| +4.00% | +7.51% | +63.67% | +68.77% | 45.75B | ||
| -0.77% | -0.67% | -15.34% | -15.95% | 22.98B | ||
| +2.93% | +1.17% | -3.97% | +384.78% | 20.76B | ||
| +1.50% | +3.93% | +27.35% | -17.35% | 16.26B | ||
| +1.16% | +3.86% | +20.23% | -36.42% | 15.42B | ||
| -1.08% | -3.11% | +27.20% | +158.30% | 13.05B | ||
| +3.30% | +15.02% | +133.24% | +273.89% | 12.45B | ||
| +1.99% | -5.92% | +22.16% | - | 12.37B | ||
| Average | +1.59% | +2.16% | +38.17% | +116.90% | 23.8B | |
| Weighted average by Cap. | +2.23% | +3.17% | +43.54% | +108.89% |
Employees
31
















